Iridex (IRIX) Cash from Investing Activities (2011 - 2026)
Iridex (IRIX) recorded quarterly Cash from Investing Activities of -$101000.0 in Q2 2026, up 4.72% quarter-over-quarter from -$106000.0 in Q1 2026, and down 818.18% on a YoY basis from $14063.3 in Q2 2025.
Iridex (IRIX) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Iridex's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$101000.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 818.18% year-over-year to -$101000.0; the TTM figure through Apr 2026 stood at -$233000.0 (down 1009.52% YoY), while the FY2026 annual figure was -$143000.0, down 1000.0% from the prior year.
- Cash from Investing Activities was -$101000.0 for Q2 2026 at Iridex, up from -$106000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $32000.0 in Q4 2023 to a low of -$5.5 million in Q1 2022.
- Historically, Cash from Investing Activities has averaged -$360235.3 across 5 years, with a median of -$26000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities soared 138.55% in 2023, then tumbled 1200.0% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$83000.0 in 2022, then jumped by 138.55% to $32000.0 in 2023, then slumped by 128.12% to -$9000.0 in 2024, then slumped by 44.44% to -$13000.0 in 2025, then sank by 676.92% to -$101000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$101000.0 (Q2 2026), -$106000.0 (Q1 2026), and -$13000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn | -101,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -101,000.00 |
| Apr 4, 2026 | -101,000.00 |
| Jan 3, 2026 | -106,000.00 |
| Jan 3, 2026 | -106,000.00 |
| Sep 27, 2025 | -13,000.00 |
| Sep 27, 2025 | -13,000.00 |
| Jun 28, 2025 | -13,000.00 |
| Jun 28, 2025 | -13,000.00 |
| Mar 29, 2025 | -11,000.00 |
| Mar 29, 2025 | -11,000.00 |
| Dec 28, 2024 | -9,000.00 |
| Dec 28, 2024 | -9,000.00 |
| Sep 28, 2024 | -1,000.00 |
| Sep 28, 2024 | -1,000.00 |
| Mar 30, 2024 | -3,000.00 |
| Mar 30, 2024 | -3,000.00 |
| Dec 30, 2023 | 32,000.00 |
| Dec 30, 2023 | 32,000.00 |
| Sep 30, 2023 | -82,000.00 |
| Sep 30, 2023 | -82,000.00 |